Cetera Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $2.7M | Buy |
62,998
+33,642
| +115% | +$1.44M | 0.02% | 686 |
|
2023
Q4 | $1.09M | Sell |
29,356
-4,406
| -13% | -$163K | 0.02% | 745 |
|
2023
Q3 | $1.22M | Sell |
33,762
-60,501
| -64% | -$2.19M | 0.02% | 643 |
|
2023
Q2 | $3.36M | Sell |
94,263
-6,066
| -6% | -$216K | 0.05% | 327 |
|
2023
Q1 | $3.57M | Sell |
100,329
-465
| -0.5% | -$16.5K | 0.06% | 303 |
|
2022
Q4 | $3.54M | Buy |
100,794
+18,859
| +23% | +$663K | 0.06% | 300 |
|
2022
Q3 | $2.41M | Buy |
81,935
+4,073
| +5% | +$120K | 0.06% | 318 |
|
2022
Q2 | $4.24M | Sell |
77,862
-287
| -0.4% | -$15.6K | 0.1% | 209 |
|
2022
Q1 | $4.26M | Buy |
78,149
+9,192
| +13% | +$500K | 0.08% | 249 |
|
2021
Q4 | $3.8M | Sell |
68,957
-9,612
| -12% | -$530K | 0.08% | 261 |
|
2021
Q3 | $3.75M | Buy |
78,569
+17,238
| +28% | +$823K | 0.07% | 279 |
|
2021
Q2 | $3.05M | Buy |
61,331
+3,352
| +6% | +$167K | 0.07% | 277 |
|
2021
Q1 | $2.59M | Buy |
57,979
+5,181
| +10% | +$231K | 0.07% | 266 |
|
2020
Q4 | $2.43M | Buy |
52,798
+15,596
| +42% | +$718K | 0.08% | 236 |
|
2020
Q3 | $1.75M | Buy |
37,202
+12,579
| +51% | +$592K | 0.07% | 270 |
|
2020
Q2 | $1.26M | Buy |
24,623
+536
| +2% | +$27.3K | 0.05% | 312 |
|
2020
Q1 | $1.14M | Sell |
24,087
-20,081
| -45% | -$951K | 0.06% | 298 |
|
2019
Q4 | $2.59M | Sell |
44,168
-697
| -2% | -$40.9K | 0.11% | 188 |
|
2019
Q3 | $2.4M | Buy |
44,865
+3,937
| +10% | +$210K | 0.11% | 189 |
|
2019
Q2 | $2.04M | Buy |
40,928
+874
| +2% | +$43.6K | 0.09% | 212 |
|
2019
Q1 | $2.09M | Buy |
40,054
+26,588
| +197% | +$1.39M | 0.1% | 189 |
|
2018
Q4 | $643K | Buy |
13,466
+2,564
| +24% | +$122K | 0.04% | 413 |
|
2018
Q3 | $543K | Buy |
10,902
+6,680
| +158% | +$333K | 0.03% | 533 |
|
2018
Q2 | $209K | Sell |
4,222
-1,258
| -23% | -$62.3K | 0.01% | 794 |
|
2018
Q1 | $267K | Buy |
5,480
+313
| +6% | +$15.3K | 0.02% | 649 |
|
2017
Q4 | $231K | Buy |
5,167
+428
| +9% | +$19.1K | 0.01% | 673 |
|
2017
Q3 | $237K | Sell |
4,739
-7,751
| -62% | -$388K | 0.01% | 695 |
|
2017
Q2 | $672K | Sell |
12,490
-9
| -0.1% | -$484 | 0.04% | 392 |
|
2017
Q1 | $653K | Buy |
12,499
+4,809
| +63% | +$251K | 0.04% | 377 |
|
2016
Q4 | $372K | Buy |
7,690
+422
| +6% | +$20.4K | 0.03% | 482 |
|
2016
Q3 | $391K | Sell |
7,268
-288
| -4% | -$15.5K | 0.03% | 489 |
|
2016
Q2 | $407K | Buy |
7,556
+365
| +5% | +$19.7K | 0.03% | 474 |
|
2016
Q1 | $365K | Sell |
7,191
-7,243
| -50% | -$368K | 0.03% | 477 |
|
2015
Q4 | $726K | Sell |
14,434
-829
| -5% | -$41.7K | 0.06% | 326 |
|
2015
Q3 | $731K | Buy |
15,263
+806
| +6% | +$38.6K | 0.07% | 287 |
|
2015
Q2 | $751K | Buy |
14,457
+1,805
| +14% | +$93.8K | 0.06% | 311 |
|
2015
Q1 | $729K | Buy |
12,652
+4,518
| +56% | +$260K | 0.07% | 310 |
|
2014
Q4 | $434K | Buy |
8,134
+3,400
| +72% | +$181K | 0.04% | 394 |
|
2014
Q3 | $273K | Buy |
4,734
+178
| +4% | +$10.3K | 0.02% | 468 |
|
2014
Q2 | $304K | Buy |
4,556
+1,381
| +43% | +$92.1K | 0.03% | 434 |
|
2014
Q1 | $214K | Buy |
+3,175
| New | +$214K | 0.03% | 473 |
|